Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)-Reference-Cited by-同舟云学术

Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

Published:2013-02-06 Issue:1 Volume:6 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Nagafuji Koji,Miyamoto Toshihiro,Eto Tetsuya,Kamimura Tomohiko,Taniguchi Shuichi,Okamura Takashi,Ohtsuka Eiichi,Yoshida Takashi,Higuchi Masakazu,Yoshimoto Goichi,Fujisaki Tomoaki,Abe Yasunobu,Takamatsu Yasushi,Yokota Shouhei,Akashi Koichi,Harada Mine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/1756-8722-6-14.pdf

Reference37 articles.

1. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 1988, 71: 123-131.

2. Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C: Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004, 101: 2788-2801. 10.1002/cncr.20668.

3. Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N: Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005, 106: 3760-3767. 10.1182/blood-2005-04-1623.

4. Lazarus HM, Richards SM, Chopra R, Litzow MR, Burnett AK, Wiernik PH, Franklin IM, Tallman MS, Cook L, Buck G: Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood. 2006, 108: 465-472. 10.1182/blood-2005-11-4666.

5. Le QH, Thomas X, Ecochard R, Iwaz J, Lheritier V, Michallet M, Fiere D: Initial and late prognostic factors to predict survival in adult acute lymphoblastic leukaemia. Eur J Haematol. 2006, 77: 471-479. 10.1111/j.1600-0609.2006.00753.x.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmented use of L-asparaginase markedly improves AYA ALL outcomes: FBMTG prospective MRD2014 study;Blood Neoplasia;2024-09

2. A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation;Bone Marrow Transplantation;2024-01-24

3. Challenges of detecting measurable/minimal disease in acute leukemia;Seminars in Diagnostic Pathology;2023-05

4. Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation;Frontiers in Oncology;2023-02-22

5. The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL);Journal of Clinical and Experimental Hematopathology;2023